Applied DNA Sciences (APDN) Misses Q4 EPS by 30c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. FLG
4. GMAB
5. ACCV
6. QQQ
7. SPCX
8. AZN
9. APO
10. META

Go back to Applied DNA Sciences (APDN) Misses Q4 EPS by 30c, Revenues Miss

Applied DNA Reports 2020 Year End and Fiscal Fourth Quarter Financial Results

December 17, 2020 4:05 PM EST

- Receives Second Warrant Exercise Subsequent to Year-End for Net Proceeds of $1.05 Million

- Company to Hold Conference Call and Webcast Today, Thursday, December 17, 2020 at 4:30 PM ET -

STONY BROOK, N.Y.--(BUSINESS WIRE)-- Applied DNA Sciences, Inc. (NASDAQ: APDN) (Applied DNA or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, today announced consolidated financial results for the full fiscal year and quarter ended September 30, 2020.

Our activities in fiscal 2020 were principally devoted to the establishment of our diagnostic and surveillance testing... More